Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis
Alves C, Ribeiro I, Penedones A, Mendes D, Batel Marques F
Ophthalmic Res. 2016 Jul 13;57(1):60-69. DOI:10.1159/000446845
2017
https://www.karger.com/Article/Abstract/446845
A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.
Carlos Alves, Ana Penedones, Diogo Mendes and Francisco Batel Marques
Acta Ophthalmol. 2016 Feb 5. doi: 10.1111/aos.12931.
2016
http://onlinelibrary.wiley.com/doi/10.1111/aos.12931/abstract;jsessionid=0857755765BEDB9128402C8C786E8567.f01t02
Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone
Mendes D, Alves C, Batel Marques F
Pharmacoepidemiol Drug Saf. 2015 Sep 16. doi: 10.1002/pds.3874.
2015
http://www.ncbi.nlm.nih.gov/pubmed/26376779
Segurança dos Medicamentos Biológicos Oftálmicos: Revisão Sistemática
Penedones A, Mendes D, Alves C, Batel Marques F
Rev Port Farmacoter 2015; 7: 28-44
2015
Financiamento da Inovação em Oncologia
Gouveia Pinto C, Varela C, Batel Marques F, Oliveira J, Espírito Santo J, Aranda da Silva J, Pazos MI, Gouveia M, Miranda N
Rev Port Farmacoter 2015; 7: 54-57
2015
Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade
Penedones A, Mendes D, Alves C, Batel Marques F
J Ocul Pharmacol Ther. 2015 Jun;31(5):258-68.
2015
http://www.ncbi.nlm.nih.gov/pubmed/25871404
Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit
Batel Marques F, Mendes D, Alves C, Penedones A, Dias P, Martins A, Santiago LM, Fontes-Ribeiro C, Caramona M, Macedo T
Acta Med Port 2015 Mar-Apr; 28(2):222-232
2015
http://www.ncbi.nlm.nih.gov/pubmed/?term=Pharmacovigilance+in+Portugal%3A+Activity+of+the+Central+Pharmacovigilance+Unit
The role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Dias P, Penedones A, Alves C, Fontes Ribeiro C, Batel Marques F
Current Drug Saf. 2015, 10(2): 000-000
2015
http://www.ncbi.nlm.nih.gov/pubmed/?term=The+role+of+Disproportionality+Analysis+of+Pharmacovigilance+Databases+in+Safety+Regulatory+Actions%3A+a+Systematic+Review
Pharmacies and the Economic Crisis in Portugal: A Case-Study
Aguiar AH, Martins L, Batel Marques F
Inernational Journal of Health Sciences June 2015, Vol. 3 , No. 2, pp. 43-47.
2015
Medidas de desproporcionalidade na deteção de sinal em farmacovigilância
Dias P, Fontes Ribeiro C, Batel Marques F
Revista Portuguesa de Farmacoterapia 2014; 6: 31-35
2014
